Immune Responses With Reduxium

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

January 27, 2021

Conditions
Immune ToleranceViral Infection
Interventions
DIETARY_SUPPLEMENT

Reduxium

Single-centre, one-arm, prospective study of 20 healthy subjects who will be given Reduxium supplementation for 14 days.

Trial Locations (3)

117456

National University of Singapore - The N.1 Institute for Health, Singapore

117597

National University of Singapore - Yong Loo Lin School of Medicine, Singapore

119074

National University Hospital, Singapore

Sponsors
All Listed Sponsors
collaborator

National University of Singapore

OTHER

lead

Ogevity Therapeutics, Inc.

INDUSTRY

NCT04525456 - Immune Responses With Reduxium | Biotech Hunter | Biotech Hunter